What does it take to move innovative science from the lab toward the patient?
In this episode of We Know Development™, Mark van Eldijk, Vice President of Science and Technology at Ardena, discusses nanoparticles, advanced drug development, and the challenges of translating complex technologies into medicines that can make a real impact.
Discover the science, decisions, and expertise behind the journey from nanoparticles to patients.
